Table 1 Expression of IMP3

From: Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations

Diagnosis

% of positive cells

Staining intensity

 

>50%

21–50%

6–20%

1–5%

Negative

Strong

Intermediate

weak

Serous carcinoma (n=45)

39/45 (86%)

3/45 (7%)

3/45 (7%)

0/45 (0%)

0/45 (0%)

38/45 (84%)

7/45 (16%)

0/45 (0%)

Endometrioid adenocarcinoma (n=122)

8/122 (7%)

10/122 (8%)

20/122 (16%)

30/122 (25%)

54/122 (44%)

34/122 (28%)

26/122 (21%)

8/122 (7%)

Benign endometrium (n=20)

0/20 (0%)

0/20 (0%)

0/20 (0%)

0/20 (0%)

20/20 (100%)

0/20 (0%)

0/20 (0%)

0/20 (0%)